Eli Lilly completes acquisition of Centessa Pharmaceuticals for $38 per share plus CVRs
Eli Lilly and Company completed its acquisition of Centessa Pharmaceuticals plc on June 24, 2026, pursuant to a court-sanctioned scheme of arrangement under…
$38.00cash$9.00per share